Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1895 1
1928 1
1938 1
1946 1
1947 2
1948 2
1949 2
1950 5
1951 3
1952 5
1953 8
1954 7
1955 1
1956 5
1957 3
1958 4
1959 3
1960 2
1961 1
1962 1
1963 5
1964 21
1965 58
1966 62
1967 51
1968 49
1969 64
1970 47
1971 19
1972 53
1973 47
1974 31
1975 88
1976 90
1977 100
1978 87
1979 158
1980 123
1981 72
1982 79
1983 124
1984 139
1985 124
1986 131
1987 113
1988 139
1989 139
1990 141
1991 144
1992 183
1993 223
1994 186
1995 205
1996 222
1997 219
1998 228
1999 237
2000 232
2001 242
2002 296
2003 291
2004 326
2005 327
2006 341
2007 389
2008 424
2009 443
2010 504
2011 599
2012 625
2013 709
2014 830
2015 1011
2016 1077
2017 1081
2018 1267
2019 1408
2020 1502
2021 1630
2022 152
Text availability
Article attribute
Article type
Publication date

Search Results

18,165 results
Results by year
Filters applied: . Clear all The following term was not found in PubMed: Tisov
Page 1
Did you mean and tisom (3 results)?
Biochemistry, Antinuclear Antibodies (ANA).
Nosal RS, Superville SS, Varacallo M. Nosal RS, et al. 2021 Nov 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2021 Nov 9. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 30725756 Free Books & Documents. Review.
The antinuclear antibody (ANA) is a defining feature of connective tissue autoimmune disorders. ANAs are a class of antibodies that bind to cellular components in the nucleus including proteins, DNA, RNA, and nucleic acid-protein complexes. First described in 1948, ANA
The antinuclear antibody (ANA) is a defining feature of connective tissue autoimmune disorders. ANAs are a class of antibodies that b …
Distribution Characteristics of ANA and ANCA in Patients with Hyperthyroidism.
Xun C. Xun C. Endocr Metab Immune Disord Drug Targets. 2021;21(11):1993-1997. doi: 10.2174/1871530320999201111160420. Endocr Metab Immune Disord Drug Targets. 2021. PMID: 33183213
In clinical practice, we have found that ANA and ANCA often occur in sera of patients with hyperthyroidism. ...RESULTS: ANA and ANCA positive rates were higher in hyperthyroidism (33.9% and 29.2%, respectively) than those in control (4.0% and 2.0%, respectively); th …
In clinical practice, we have found that ANA and ANCA often occur in sera of patients with hyperthyroidism. ...RESULTS: ANA an …
Evaluation of the LIA-ANA-Profile-17S for the detection of autoantibodies to nuclear antigens.
Yi A, Lee CH, Moon HW, Kim H, Hur M, Yun YM. Yi A, et al. Clin Biochem. 2018 May;55:75-79. doi: 10.1016/j.clinbiochem.2018.03.020. Epub 2018 Mar 30. Clin Biochem. 2018. PMID: 29608892 Clinical Trial.
METHODS: Residual samples were collected from 200 patients who had been tested for ANA using indirect immunofluorescence. The LIA-ANA-Profile-17S was compared to the EuroLine ANA (Euroimmun, Oberlausitz, Germany) for the analysis of 17 different autoantibodie …
METHODS: Residual samples were collected from 200 patients who had been tested for ANA using indirect immunofluorescence. The LIA- …
ANA testing in the presence of acute and chronic infections.
Litwin CM, Binder SR. Litwin CM, et al. J Immunoassay Immunochem. 2016;37(5):439-52. doi: 10.1080/15321819.2016.1174136. J Immunoassay Immunochem. 2016. PMID: 27050929 Review.
However, a positive ANA test may also be seen with non-autoimmune inflammatory diseases, including both acute and chronic infections. ...This article identifies acute and chronic infectious diseases that are likely to produce a positive ANA result and summarizes rec …
However, a positive ANA test may also be seen with non-autoimmune inflammatory diseases, including both acute and chronic infections. …
Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis.
Choi MY, Cui J, Costenbader K, Rydzewski D, Bernhard L, Schur P. Choi MY, et al. Lupus Sci Med. 2020 Nov;7(1):e000431. doi: 10.1136/lupus-2020-000431. Lupus Sci Med. 2020. PMID: 33154098 Free PMC article. Review.
Sensitivity of HEp-2 ANA, ML ANA, repeating HEp-2 ANA, and combining HEp-2 and ML ANA assays was assessed. ...In SLE, the presence of anti-dsDNA antibodies was predictive of ANA agreement between HEp-2 and ML ANA (adjusted OR 6.27, 95% CI …
Sensitivity of HEp-2 ANA, ML ANA, repeating HEp-2 ANA, and combining HEp-2 and ML ANA assays was assessed. ...In …
ANA-Negative Hydralazine-Induced Pericardial Effusion.
Zeitjian V, Mehdizadeh A. Zeitjian V, et al. Case Rep Med. 2017;2017:3521541. doi: 10.1155/2017/3521541. Epub 2017 Dec 17. Case Rep Med. 2017. PMID: 29391867 Free PMC article.
It is typically common to screen for DILE with the serum ANA test prior to proceeding to more costly and specific tests (i.e., anti-histone antibody). As per our literature review, this is the second case of hydralazine causing DILE with a negative ANA. As in our ca …
It is typically common to screen for DILE with the serum ANA test prior to proceeding to more costly and specific tests (i.e., anti-h …
["Pro Ana": Psychodynamic References for Anorexia Nervosa].
Siefert L. Siefert L. Prax Kinderpsychol Kinderpsychiatr. 2017 Feb;66(2):88-103. doi: 10.13109/prkk.2017.66.2.88. Prax Kinderpsychol Kinderpsychiatr. 2017. PMID: 28142631 German.
"Pro Ana": Psychodynamic References for Anorexia Nervosa The internet-based phenomenon "Pro Ana" refers to the eating disorder anorexia nervosa in a positive way. To understand what the phenomenon "Pro Ana" represents, the websites are used as a starting poin …
"Pro Ana": Psychodynamic References for Anorexia Nervosa The internet-based phenomenon "Pro Ana" refers to the eating disorder …
Choosing wisely: Review and commentary on anti-nuclear antibody (ANA) testing.
Fritzler MJ. Fritzler MJ. Autoimmun Rev. 2016 Mar;15(3):272-80. doi: 10.1016/j.autrev.2015.12.002. Epub 2015 Dec 11. Autoimmun Rev. 2016. PMID: 26687321 Review.
It is suggested that if the sole use of ANA testing is to add evidence to support a diagnosis when the pre-test probability is high, then the ANA test has limited clinical value. ...One CW recommendation that bears emphasizing is that, with a few possible exceptions …
It is suggested that if the sole use of ANA testing is to add evidence to support a diagnosis when the pre-test probability is high, …
[Chances and Pitfalls of ANA and ANCA Diagnostics].
Di Chiara M. Di Chiara M. Praxis (Bern 1994). 2020;109(5):325-331. doi: 10.1024/1661-8157/a003439. Praxis (Bern 1994). 2020. PMID: 32233767 German.
Chances and Pitfalls of ANA and ANCA Diagnostics Abstract. In the context of clinical manifestations, if analysed with high quality laboratory methods and correctly interpreted, ANA and ANCA are an essential tool in the differential diagnosis of rheumatic diseases. …
Chances and Pitfalls of ANA and ANCA Diagnostics Abstract. In the context of clinical manifestations, if analysed with high quality l …
High-Titre ANA Positivity in NAFLD: An Uncommon Presentation of a Common Disease.
Mitra A, Ray S. Mitra A, et al. Eur J Case Rep Intern Med. 2020 Jun 8;7(9):001714. doi: 10.12890/2020_001714. eCollection 2020. Eur J Case Rep Intern Med. 2020. PMID: 32908830 Free PMC article.
About 20% of NAFLD patients may have low titres (<1:320) of antinuclear antibodies (ANA). However, we describe a patient with NAFLD whose ANA titre was high (>1:320) on presentation. ...LEARNING POINTS: Up to 30% of patients with non-alcoholic fatty liver dise …
About 20% of NAFLD patients may have low titres (<1:320) of antinuclear antibodies (ANA). However, we describe a patient with NAFL …
18,165 results
You have reached the last available page of results. Please see the User Guide for more information.